DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lidanserin
Lidanserin
Chemical Ligand Space of Cereblon Iuliia Boichenko,† Kerstin Bar,̈ Silvia Deiss, Christopher Heim, Reinhard Albrecht, Andrei N
Ep 1553091 A1
GPCR/G Protein
Fagin-Event-Laurahaas.Pdf
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
WHO Drug Information Vol. 03, No. 4, 1989
(12) Patent Application Publication (10) Pub. No.: US 2009/0053329 A1 Peters Et Al
Stembook 2018.Pdf
Combinations of 5-Ht2a Inverse Agonists And
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(19) United States (12) Reissued Patent (10) Patent Number: US RE41,998 E Campbell (45) Date of Reissued Patent: Dec
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
O-Ribose Methyltransferase Nsp16 of SARS-Cov-2
5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
Harmonized Tariff Schedule of the United States (2006) (Rev
Top View
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) United States Patent (10) Patent No.: US 9,050,343 B2 Peters Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Endocrinology
Adrenergic Receptor Beta Receptor
(12) Patent Application Publication (10) Pub. No.: US 2013/0143901 A1 PETERS Et Al
Adrenergic Receptor Beta Receptor